We have examined extracts of fibroblasts from patients with mannosidosis, mucolipidosis (ML) II, ML Ill, and normal controls for a-D-mannosidase activity against 4-m?thylumbelliferyla-0.mannopyranoside to test for the presence of the "intermediate" pH 5.5 enzyme activity that has been called the "Golgi mannosidase." Fibroblast extracts were prepared by sonication and sedimented to separate membrane-associated activities from cytosolic and lysosomal a-D-mannosidases. Membranes were extracted by salt washes (0.4 M NaCI) to desorb the lysosomal enzymes that sedimented with menbranes. The a-D-mannosidase activity remaining with membranes showed n l n y properties described for the Golgi mannosidase including: 1) an "intermeliate" pH optimum (pH 5.5-6.0), 2) activity with the synthetic 4-methylumbelliferyl substrate, 3) lack of inhibitability by 200 mM methyl-a-D-mannopyranoside and4) partial resistance to solub~lization by salt washing, and to a single extraction with the non-ionic detergent Triton X-100.
INTRODUCTION
Animal tissues contain multiple a-D-mannosidases ( a -0-mannoside mannohydrolase EC 3.2.1.24) which have distinct properties, subcellular localizations, and functions. Lysosomal a -D-mannosidase, also called "acid" a-D-mannosidase because its pH optimum i s below pH 5.0, i s important in the catabolism of macromolecules containing a-D-mannosyl residues (glycoproteins and some forms of keratan sulfate). An inherited deficiency for this enzyme produces a lysosomal storage disease called mannosidosis which has been recognized in man (15, 21) and cattle (23). Only the lysosomal enzyme form i s affected by the mutation producing mannosidosis (2,23).
A "neutral" a-0-mannosidase has been clearly distinguished from the lysosomal form by its pH optimum (pH 6.06.5), its cytosolic localization, and by several other properties (22, 24) . Although genetic (3,4), immunologic (221, and biochemical (22) evidence all indicate that this enzyme i s unrelated to the lysosomal enzyme, the function of neutral a-D-mannosidase i s still uncertain.
The third distinct a-0-mannosidase to be identified in mammalian tissues i s the "Golgi" mannosidase which was discovered, purified, and characterized by Touster and co-workers (5, 22, 30) . This enzyme was distinguished from the previously recognized a-D-mannosidases primarily by its "intermediate" pH optimum (pH 5.5), its localization in Golgi membranes in subcellular fractions hom rat liver, and its strong association with these membranes from which i t can be solubilized only with detergents. The recent work of Tabas and Kornfeld (28.291 and of Harpaz and Shachter (11) suggested that there may be two additional a-qannosidases associated with the Golgi apparatus that play important roles in removing mannose residues during the processing of oligosaccharide chains on newly synthesized glycoproteins in the Golgi appar. atus.
I t has been suggested that a deficiency or abnormality of the Golgi mannosidase described by Dewald and Touster (6) , which has been assumed to comprise the main component of a-0-mannosidase present in normal human and bovine serum (14, 19, 34) may be important in the pathogenesis of mucolipidosis II (ML II) and mucolipidosis Ill (ML 111) (17) . ML II, also called I-cell d~sease, and ML Ill are severe and mild forms, respectively, of a lysosomal storage disease that results, not from a defect in a structural gene for a lysosomal enzyme, but rather from a defect in addition of the "common recognition marker" to acid hydrolases that allow them to be segregated into lysosomes rather than to be secreted (1, 12, 25) . Fibroblasts from these patients show deficiencies for nearly all acid hydrolases intracellularly, but also exaggerated secretion of these hydrolases into the medium (13,32,33). Sera froa affected patients show greatly elevated levels of most acid hydrolases, including a-D-mannosidase (5, 8) . On the basis of studies of the properties of the elevated a.D-mannosidase in sera from patients with ML II and ML Ill, Kress and Miller (17) suggested that "absent or altered intermediate mannosidase may be responsible for the aberrant biochevical properties reported for other glycosidases in Mucolipidosis II and Mucolipidosis Ill." We have examined extracts of normal and mutant human fibroblasts directly for a membrane-associated enzyme with the properties reported for the Golgi mannosidase described by Touster's group (6, 22, 30) . The purpose of this report i s to present studies which show that such an activity could be lemonstrated in extracts from normal human fibroblasts and that this activity was undiminished in fibroblasts from patients with lysosomal a -D-mannosidase deficiency, patients with isolated neuraminidase deficiency, also called vucolipidosis I (ML I), and also i n fibroblasts from patients with ML II and ML Ill. These studies provide no evidence to support the suggestion that a deficiency of the "intermed~ate" a-0-mannosidase (i.e., the Golgi mannosidase described by Touster and co.workers) (5, 22 .301 contributes to the abnormal localization (secretion rather than retention in lysosomes) or the abnormal processing (1. 12, 16, 25, 26, 27) Fibroblasts were cultured as previously described (10) . Cell cultures were harvested between 2 and 3 weeks after subculture. After removing the media, roller bottles were washed twice either with phosphate buffered saline (PBS) or normal saline. Cells were scraped from the roller bottle with a rubber policeman into either PBS or normal saline and washed twice by resedimentation in the same solution at 1000 rpm for 5 min in a clinical centrifuge. The pellet was resuspended in 6 volumes of either 0.005 M Hepes buffer. pH 7.6 or distilled water and sonicated on ice with a miniprobe for two periods of 12 seconds each at setting 30 (Biosonik Ill apparatus, Bronville Sci., Rochester, N.Y.). Part of this material, called crude sonicate (CS), was centrifuged at 30.000 x g for 15 min in a Sorvall refrigerated centrifuge, model RC-3. The supernatant (S1) and part of the pellet (Pi) were saved for enzymatic assays and protein determination. The rest of the pellet was washed twice with 0.4 M NaCl by resedimentation at 30,000 r g for 15 min. The final pellet (P3) was resuspended in either 0.005 M Hepes buffer pH 7.6 or in distilled water. All operations were carried out at ( 4 .
Enzymatic assays
Enzyme activities were determined flourometrically as previously described (9). Synthetic substrates were 4-methylumbelliferyl-o -0-mannopyranoside. 8 mM in 0.1 M sodium acetate buffer, pH 4.0 or 5.5, for a-D-mannosidase activity, and 4-methylumbelliferyl-P-D-N-acetylglucosaminide, 1 mM in 0.02 M sodium phosphate-citrate buffer, pH 4.4, for B-D-hexosaminidase activity.
Assays were carried out by incubating 25 of enzyme solution and 10OP1 of substrate at 37 for 3060 min. Reactions were stopped by addine 1.8 ml of flycine-carbonate buffer, pH 10.5. All assays were performed in duplicate. When necessary, enzyme preparations were diluted with the assay buffer solution containing 0.075 M NaCI, 1 mg'ml human serum albumin and 0.001% Triton X-100. One unit i s defined as the amount of enzyme that releases 1 nanomole of 4-methylumbelliferone per hour. After 20 min, the suspension was centrifuged at 105,000 x g for 1 h in a Beckman L 2 6 5 B ultracentrifuge and the sediment used for assays.
Several a-D-mannosidase activities in crude mammalian cell extracts contribute to the hydrolysis of 4-methylumbelliferyl-a-D-mannopyranoside at pH 4.0 and at pH 5.5, the pH optima of the "acid" lysosomal a-D.mannosidase and the "intermediate" one which has been found to be associated with membranes from the Golgi com~lex. Dewald and Touster (6) devised a fractionation scheme for rat liver to demonstrate the different subcellular localizations and properties of the pH 4.0 lysosomal a-D-mannosidase and the pH 5.5 "intermediate" Golgi mannosidase, and showed that the small amount of lysosomal enzyme that sedimented with Golgi membranes c o~~l d be desorbed by salt washing with 0.4 M NaCI. We have used a simple cell disruption method (sonication) to release lysosomal enzymes from cultured fibroblasts and a wash of the sedimentable wambranes similar to that described by Dewald and Touster (6) 
